ACR 20: Clinical or statistical significance?

[41] PINCUS T, 1986, J RHEUMATOL, V13, P841

[42] PINCUS T, 1993, AGENT ACTION SUPPL, V44, P83

[43] PINCUS T, 1995, J RHEUMATOL, V22, P1611

[44] LIMITATIONS OF RANDOMIZED CLINICAL-TRIALS TO RECOGNIZE POSSIBLE ADVANTAGES OF COMBINATION THERAPIES IN RHEUMATIC DISEASES [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) : 2 - 10

[45] PINCUS T, 1992, J RHEUMATOL, V19, P1885

[46] PINCUS T, 1995, BRIT J RHEUMATOL, V34, P196

[47] PINCUS T, 1997, ADVANCES, V13, P3

[48] SANY J, 1991, J RHEUMATOL, V18, P1323

[49] Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks - An open-label extension study [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (10): : 1843 - 1851

[50] Stenger AAME, 1998, BRIT J RHEUMATOL, V37, P1157

[41] PINCUS T, 1986, J RHEUMATOL, V13, P841

[42] PINCUS T, 1993, AGENT ACTION SUPPL, V44, P83

[43] PINCUS T, 1995, J RHEUMATOL, V22, P1611

[44] LIMITATIONS OF RANDOMIZED CLINICAL-TRIALS TO RECOGNIZE POSSIBLE ADVANTAGES OF COMBINATION THERAPIES IN RHEUMATIC DISEASES [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) : 2 - 10

[45] PINCUS T, 1992, J RHEUMATOL, V19, P1885

[46] PINCUS T, 1995, BRIT J RHEUMATOL, V34, P196

[47] PINCUS T, 1997, ADVANCES, V13, P3

[48] SANY J, 1991, J RHEUMATOL, V18, P1323

[49] Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks - An open-label extension study [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (10): : 1843 - 1851

[50] Stenger AAME, 1998, BRIT J RHEUMATOL, V37, P1157